Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Priya Mahajan

Showing results (21-30 of 44) with videos related to

Pageof 5
Sort By:
Pediatrics|November 13, 2025
Selpercatinib Increases Radioactive Iodine Avidity in RET-Fusion Pediatric Thyroid CarcinomaSamara L Potter, Nino Rainusso, Andrew C Sher, et al.
Cancer Research|July 24, 2019
Selective Targeting of Myoblast Fusogenic Signaling and Differentiation-Arrest Antagonizes Rhabdomyosarcoma CellsValerie A Granados, Usha Avirneni-Vadlamudi, Pooja Dalal, et al.
Thyroid : Official Journal of the American Thyroid Association|September 19, 2018
Response to Lenvatinib in Children with Papillary Thyroid CarcinomaPriya Mahajan, Jonathan Dawrant, Albert Kheradpour, et al.
Pediatric Blood & Cancer|April 12, 2021
Peptide receptor radionuclide therapy for treatment of metastatic neuroendocrine tumors in childrenJennifer H Foster, Andrew Sher, Victor Seghers, et al.
European Journal of Medicinal Chemistry|November 17, 2016
Synthesis of α-santonin derivatives for diminutive effect on T and B-cell proliferation and their structure activity relationshipsPraveen K Chinthakindi, Jasvinder Singh, Shilpa Gupta, et al.
The Journal of Surgical Research|August 28, 2022
Institutional Management of Abdominal Lymphatic Malformations: Evolution of Treatment Over a DecadeSteven C Mehl, Austin Kinley, Hannah F Todd, et al.
European Journal of Pharmacology|June 17, 2019
Rottlerin is a pan phosphodiesterase inhibitor and can induce neurodifferentiation in IMR-32 human neuroblastoma cellsMohd Ishaq Dar, Priya Mahajan, Suraya Jan, et al.
Medicinal Chemistry (Shariqah (United Arab Emirates))|October 16, 2012
Structure activity relationship of arylidene pyrrolo and pyrido [2,1-b] quinazolones as cytotoxic agents: synthesis, SAR studies, biological evaluation and docking studiesVeenu Mangla, Kunal Nepali, Gagandip Singh, et al.
Bioorganic & Medicinal Chemistry|July 12, 2015
4-(N-Phenyl-N'-substituted benzenesulfonyl)-6-(4-hydroxyphenyl)quinolines as inhibitors of mammalian target of rapamycinVunnam Venkateswarlu, Anup Singh Pathania, K A Aravinda Kumar, et al.
European Journal of Medicinal Chemistry|May 1, 2014
Synthesis of 5-substituted-1H-pyrazolo[4,3-d]pyrimidin-7(6H)-one analogs and their biological evaluation as anticancer agents: mTOR inhibitorsG Lakshma Reddy, Santosh Kumar Guru, M Srinivas, et al.
Pageof 5

Showing results (21-30 of 44) with videos related to

Sort By:
Pageof 5
Pediatrics|November 13, 2025
Selpercatinib Increases Radioactive Iodine Avidity in RET-Fusion Pediatric Thyroid CarcinomaSamara L Potter, Nino Rainusso, Andrew C Sher, et al.
Cancer Research|July 24, 2019
Selective Targeting of Myoblast Fusogenic Signaling and Differentiation-Arrest Antagonizes Rhabdomyosarcoma CellsValerie A Granados, Usha Avirneni-Vadlamudi, Pooja Dalal, et al.
Thyroid : Official Journal of the American Thyroid Association|September 19, 2018
Response to Lenvatinib in Children with Papillary Thyroid CarcinomaPriya Mahajan, Jonathan Dawrant, Albert Kheradpour, et al.
Pediatric Blood & Cancer|April 12, 2021
Peptide receptor radionuclide therapy for treatment of metastatic neuroendocrine tumors in childrenJennifer H Foster, Andrew Sher, Victor Seghers, et al.
European Journal of Medicinal Chemistry|November 17, 2016
Synthesis of α-santonin derivatives for diminutive effect on T and B-cell proliferation and their structure activity relationshipsPraveen K Chinthakindi, Jasvinder Singh, Shilpa Gupta, et al.
The Journal of Surgical Research|August 28, 2022
Institutional Management of Abdominal Lymphatic Malformations: Evolution of Treatment Over a DecadeSteven C Mehl, Austin Kinley, Hannah F Todd, et al.
European Journal of Pharmacology|June 17, 2019
Rottlerin is a pan phosphodiesterase inhibitor and can induce neurodifferentiation in IMR-32 human neuroblastoma cellsMohd Ishaq Dar, Priya Mahajan, Suraya Jan, et al.
Medicinal Chemistry (Shariqah (United Arab Emirates))|October 16, 2012
Structure activity relationship of arylidene pyrrolo and pyrido [2,1-b] quinazolones as cytotoxic agents: synthesis, SAR studies, biological evaluation and docking studiesVeenu Mangla, Kunal Nepali, Gagandip Singh, et al.
Bioorganic & Medicinal Chemistry|July 12, 2015
4-(N-Phenyl-N'-substituted benzenesulfonyl)-6-(4-hydroxyphenyl)quinolines as inhibitors of mammalian target of rapamycinVunnam Venkateswarlu, Anup Singh Pathania, K A Aravinda Kumar, et al.
European Journal of Medicinal Chemistry|May 1, 2014
Synthesis of 5-substituted-1H-pyrazolo[4,3-d]pyrimidin-7(6H)-one analogs and their biological evaluation as anticancer agents: mTOR inhibitorsG Lakshma Reddy, Santosh Kumar Guru, M Srinivas, et al.
Pageof 5